These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2521 related items for PubMed ID: 8043388

  • 1. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6.
    Mckenzie RC, Park ES, Brown WR, Shivji GS, Sauder DN.
    Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):74-9. PubMed ID: 8043388
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC, Oran A, Dinarello CA, Sauder DN.
    Anticancer Res; 1996 Apr; 16(1):437-41. PubMed ID: 8615650
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE, Dinarello CA.
    Cancer Res; 1991 May 01; 51(9):2379-85. PubMed ID: 2015601
    [Abstract] [Full Text] [Related]

  • 4. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
    Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N.
    Thromb Haemost; 1995 Dec 01; 74(6):1511-5. PubMed ID: 8772229
    [Abstract] [Full Text] [Related]

  • 5. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.
    Eisenthal A, Cameron RB, Rosenberg SA.
    J Immunol; 1990 Jun 01; 144(11):4463-71. PubMed ID: 2111349
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F.
    Melanoma Res; 1997 Aug 01; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [Abstract] [Full Text] [Related]

  • 8. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts.
    Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA.
    Exp Cell Res; 1998 May 25; 241(1):222-9. PubMed ID: 9633531
    [Abstract] [Full Text] [Related]

  • 9. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
    Martínez-Esparza M, Solano F, García-Borrón JC.
    Cell Mol Biol (Noisy-le-grand); 1999 Nov 25; 45(7):991-1000. PubMed ID: 10644003
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec 25; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of interleukin 8 expression in human malignant melanoma cells.
    Singh RK, Varney ML.
    Cancer Res; 1998 Apr 01; 58(7):1532-7. PubMed ID: 9537260
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
    Gutman M, Singh RK, Xie K, Bucana CD, Fidler IJ.
    Cancer Res; 1995 Jun 01; 55(11):2470-5. PubMed ID: 7758001
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 127.